Progyny PGNY
NASDAQ PGNY
$27.13 +0.12 (+0.44%)
At close: Sep 18, 2026 · 4:00 PM EDT

Progyny (PGNY) Invested Capital (2018 - 2019)

Progyny's (PGNY) quarterly Invested Capital came in at $114.3 million in Q4 2019, up 220.78% year-over-year from $35.6 million in Q4 2018, and up 225.23% quarter-over-quarter from -$91.2 million in Q3 2019.

Analysis

Progyny (PGNY) Invested Capital (2018 - 2019) Analysis & Trends

Progyny (PGNY) has reported Invested Capital for 2 consecutive years, with $114.3 million the latest figure, recorded in Q4 2019.

  • On a quarterly basis, Invested Capital rose 220.78% year-over-year to $114.3 million in Q4 2019; TTM through Dec 2019 was $114.3 million, a 220.78% increase from a year earlier, with the FY2019 full-year figure at $114.3 million, up 220.78% from the prior year.
  • Invested Capital was $114.3 million for Q4 2019 at Progyny, up from -$91.2 million in the prior quarter.
  • Over five years, Invested Capital peaked at $114.3 million in Q4 2019 and troughed at -$94.6 million in Q4 2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Davita 11.76 Bn 12.63 Bn 1.16 Bn 10.02 Bn
2 RadNet 5.98 Bn 5.55 Bn 88.08 Mn 2.73 Bn
3 Concentra Group Holdings Parent 4.52 Bn 4.39 Bn 192.10 Mn 2.06 Bn
4 Privia Health 2.51 Bn 2.15 Bn - -
5 Pediatrix Medical 2.11 Bn 1.70 Bn - 1.47 Bn
6 Progyny 2.10 Bn 1.86 Bn 89.30 Mn -
7 Fresenius Medical Care AG 2.07 Bn 1.37 Bn 1.52 Bn 24.88 Bn
8 Surgery Partners 1.73 Bn 2.95 Bn 622.10 Mn 6.85 Bn
9 U S Physical Therapy 1.23 Bn 1.52 Bn 41.94 Mn 622.30 Mn
10 Starling Oncology 699.26 Mn 658.17 Mn 27.17 Mn 54.95 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2019 114.27 Mn
Sep 30, 2019 -91.25 Mn
Dec 31, 2018 -94.61 Mn